Postmarketing assessment of a switchable similar anastrozole product in Brazilian breast cancer patients

Postmarketing assessment of a switchable similar anastrozole product in Brazilian breast cancer patients

Several formulations of the aromatase inhibitor anastrozole are available in Brazil. We carried out a postmarketing surveillance of the anastrozole (test) formulation in current use at the Brazilian National Cancer Institute (INCA), by comparing anastrozole through plasma concentrations obtained wit...

Full description

Bibliographic Details
Main Authors:	Manuela Vasquez Cardoso, Renata Obadia, Luna Silva, Priscila Pentagna, Rafael Linden, Vanessa Câmara Fernandes, Andreia Cristina de Melo, Guilherme Suarez-Kurtz
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia 2023-04-01
Series:	Brazilian Journal of Oncology
Subjects:	aromatase inhibitors anastrozole breast neoplasms
Online Access:	https://www.brazilianjournalofoncology.com.br/details/232/en-US/postmarketing-assessment-of-a-switchable-similar-anastrozole-product-in-brazilian-breast-cancer-patients

Similar Items

Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events
by: Yoo Jung Kim, et al.
Published: (2020-01-01)

Oral lichen sclerosus in a breast cancer patient on anastrozole therapy: A case report with brief review of literature
by: Chaturbhuj Agrawal, et al.
Published: (2017-01-01)

Nadir Bir Kutanöz Vaskülit Sebebi: Anastrozol
by: Didem Arslan TAŞ, et al.
Published: (2014-07-01)

Joint symptoms associated with anastrozole and letrozole in patients with breast cancer: a retrospective comparative study
by: Yoshihito Morimoto, et al.
Published: (2017-11-01)

Case Report: Anastrozole as a monotherapy for pre-pubertal children with non-classic congenital adrenal hyperplasia
by: Sandy C. Liu, et al.
Published: (2023-03-01)

Anastrozole monotherapy further improves near-adult height after the initial combined treatment with leuprorelin and anastrozole in early-maturing girls with compromised growth prediction: results from the second phase of the GAIL study
by: Dimitrios T. Papadimitriou, et al.
Published: (2024-04-01)

Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models
by: Beata Filip-Psurska, et al.
Published: (2021-03-01)

Investigation of genotoxicity risk and DNA repair capacity in breast cancer patients using anastrozole
by: Tugce Yesil Devecioglu, et al.
Published: (2018-02-01)

Locomotion Outcome Improvement in Mice with Glioblastoma Multiforme after Treatment with Anastrozole
by: Irene Guadalupe Aguilar-García, et al.
Published: (2023-03-01)

The Utilization and Impact of Aromatase Inhibitor Therapy in Men With Elevated Estradiol Levels on Testosterone Therapy
by: Nahid Punjani, MD, MPH, et al.
Published: (2021-08-01)

Androstenedione and Follicle-Stimulating Hormone Concentration Predict the Progression of Frailty Syndrome at One Year Follow-Up in Patients with Localized Breast Cancer Treated with Aromatase Inhibitors
by: Javier García-Sánchez, et al.
Published: (2022-07-01)

Non-aromatizable androgens modulate the lipopolysaccharide induced expression of the P2X7 receptor in human adipocytes
by: Angelo Di Vincenzo, et al.
Published: (2023-10-01)

Neoadjuvant nivolumab + palbociclib + anastrozole for oestrogen receptor-positive/human epidermal growth factor receptor 2-negative primary breast cancer: Results from CheckMate 7A8
by: Guy Jerusalem, et al.
Published: (2023-12-01)

Formulation and in-vitro Evaluation of Ethosomes using Anastrozole as a Modeling Drug
by: Neven Nasef AlEbadi, et al.
Published: (2023-01-01)

Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors
by: Cristina Ferreira Almeida, et al.
Published: (2023-04-01)

The effect of anastrozole therapy on final height and sex hormone levels in pubertal boys receiving growth hormone therapy
by: Gürkan Tarçın, et al.
Published: (2024-02-01)

Anastrozole for the prevention of breast cancer in high-risk postmenopausal women: cost-effectiveness analysis in the UK and the USA
by: XiaoXia Wei, et al.
Published: (2024-02-01)

Antiplatelet Therapy Combined with Anastrozole Induces Features of Partial EMT in Breast Cancer Cells and Fails to Mitigate Breast-Cancer Induced Hypercoagulation
by: Kutlwano R. Xulu, et al.
Published: (2021-04-01)

Role of aromatase inhibitors in managing hypogonadism in adult males related to obesity and aging: A systematic review and meta-analysis
by: Deep Dutta, et al.
Published: (2022-01-01)

Anastrozole Protects against Human Coronavirus Infection by Ameliorating the Reactive Oxygen Species–Mediated Inflammatory Response
by: Eun-Bin Kwon, et al.
Published: (2024-01-01)

Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment
by: Lu Turković, et al.
Published: (2022-05-01)

New Crystal Forms for Biologically Active Compounds. Part 2: Anastrozole as N-Substituted 1,2,4-Triazole in Halogen Bonding and Lp-π Interactions with 1,4-Diiodotetrafluorobenzene
by: Mariya A. Kryukova, et al.
Published: (2020-05-01)

Adesão à Terapia Hormonal Adjuvante com Tamoxifeno e Anastrozol utilizando ARMS-12 e MMAS-4
by: Lorena Oliveira de Botelho, et al.
Published: (2022-05-01)

Surface-Modification of Carbonate Apatite Nanoparticles Enhances Delivery and Cytotoxicity of Gemcitabine and Anastrozole in Breast Cancer Cells
by: Fitya Syarifa Mozar, et al.
Published: (2017-06-01)

Localized Cutaneous Adverse Event Induced by Anastrozole as Adjuvant Treatment for Breast Cancer: A Case Report
by: Aya Tanaka, et al.
Published: (2019-02-01)

The effect of third-generation aromatase inhibitors on aromatase avtivity in visceral adipose tissue
by: D. V. Lytkin, et al.
Published: (2018-08-01)

Optimized Polyethylene Glycolylated Polymer–Lipid Hybrid Nanoparticles as a Potential Breast Cancer Treatment
by: Salam Massadeh, et al.
Published: (2020-07-01)

Aromatase Inhibitors and Plasma Lipid Changes in Postmenopausal Women with Breast Cancer: A Systematic Review and Meta-Analysis
by: Bálint Bérczi, et al.
Published: (2024-03-01)

Familial male-limited precocious puberty due to an activating mutation of the LHCGR: a case report and literature review
by: Jihyun Ha, et al.
Published: (2024-02-01)

<i>In Vitro</i> Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment
by: Patrícia H. A. Bezerra, et al.
Published: (2023-06-01)

Aromatase inhibitors in the treatment of endometriosis
by: Radosław Słopień, et al.
Published: (2016-03-01)

The integrative bioinformatics approaches to predict the xanthohumol as anti-breast cancer molecule: Targeting cancer cells signaling PI3K and AKT kinase pathway
by: Kartikey Kumar Gupta, et al.
Published: (2022-12-01)

Reconsidering Aromatase for Breast Cancer Treatment: New Roles for an Old Target
by: Jessica Caciolla, et al.
Published: (2020-11-01)

A REGENERATIVE APPROACH TO AN ACUTE EXACERBATION OF HIP PAIN FROM AROMATASE INHIBITOR ASSOCIATED MUSCULOSKELETAL SYNDROME AND AROMATASE-INHIBITOR ARTHRALGIAS
by: Christian Vangeison, et al.
Published: (2022-10-01)

Genetic Factors of Idiopathic Gigantomastia: Clinical Implications of Aromatase and Progesterone Receptor Polymorphisms
by: Anna Kasielska-Trojan, et al.
Published: (2022-01-01)

The Role of Aromatase Inhibitors in Male Prolactinoma
by: Amit Akirov, et al.
Published: (2023-02-01)

Screening for Compounds with Aromatase Inhibiting Activities from Atractylodes macrocephala Koidz
by: Hai Jiang, et al.
Published: (2011-04-01)

Sexual quality of life in hormonotherapy for breast cancer patients
by: Pedro Paulo Perroni da Silva, et al.
Published: (2022-12-01)

Origin of aromatase inhibitory activity via proteochemometric modeling
by: Saw Simeon, et al.
Published: (2016-05-01)

Sweet’s Syndrome Induced by Aromatase Inhibitor in the Treatment of Early Breast Cancer
by: Debora Cardoso, et al.
Published: (2020-02-01)